Table 4.
Summary from the most common clinical adverse events
| DEB-TACE (n=26) | cTACE (n=122) | Y90 (n=44) | ||||
|---|---|---|---|---|---|---|
|
| ||||||
| N | (%) | N | (%) | N | (%) | |
| no symptoms | 3 | 11.5 | 18 | 14.8 | 7 | 15.9 |
| Presence of symptoms | 23 | 88.5 | 104 | 85.2 | 37 | 84.1 |
|
| ||||||
| Listed symptoms: | N | (%) | N | (%) | N | (%) |
|
| ||||||
| Abdominal pain/discomfort | 9 | 34.6 | 28 | 23.0 | 20 | 45.5 |
| Flushing | 5 | 19.2 | 35 | 28.7 | 11 | 25.0 |
| Fatigue | 4 | 15.4 | 22 | 18.0 | 4 | 9.1 |
| Nausea | 3 | 11.5 | 15 | 12.3 | 4 | 9.1 |
| Weight loss | 3 | 11.5 | 16 | 13.1 | 9 | 20.5 |
| Diarrhea | 3 | 11.5 | 44 | 36.1 | 17 | 38.6 |
| Vomiting | 2 | 7.7 | 9 | 7.4 | 0 | 0.0 |
| Anorexia | 1 | 3.8 | 2 | 1.6 | 0 | 0.0 |
| Hypoglycemia | 1 | 3.8 | 2 | 1.6 | 1 | 2.3 |
| Fever | 0 | 0.0 | 1 | 0.8 | 0 | 0.0 |
| Reflux | 0 | 0.0 | 2 | 1.6 | 1 | 2.3 |
| no symptoms vs. presence of symptoms | |||
|---|---|---|---|
|
| |||
| Comparison cohort | DEB-TACE vs. cTACE | cTACE vs. Y90 | Y90 vs. DEB-TACE |
| p-value | 1.00 | 0.81 | 0.73 |
conventional transarterial chemoembolization (cTACE), drug-eluting beads TACE (DEB-TACE), 90Yttrium Radioembolization (Y90)